An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors
NCT04993261 is a phase early 1 interventional trial sponsored by M.D. Anderson Cancer Center. As of 21 Nov 2026, it is active and no longer recruiting. It studies Carcinoid Syndrome, Carcinoid Tumor and 2 more conditions. The registry lists an enrollment of 71 participants at 1 site in 1 country. The registry lists a start date of 23 Sept 2015 and a primary completion date of 31 Dec 2026.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT04993261 |
| Status | Active not recruiting |
| Phase | Phase Early 1 |
| Study type | Interventional trial |
| Lead sponsor | M.D. Anderson Cancer Center |
| Enrollment | 71 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Carcinoid Syndrome, Carcinoid Tumor, Digestive System Neuroendocrine Tumor G1 and Metastatic Carcinoid Tumor |
| Start | 23 Sept 2015 |
| Primary completion | 31 Dec 2026 |
| Study completion | 31 Dec 2026 |
| Last update posted | 11 Aug 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Ajaykumar Morani
M.D. Anderson Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- M D Anderson Cancer Center
Houston
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT04993261
Each answer restates registry values shown on this page.
What is NCT04993261?
NCT04993261 is a phase early 1 interventional trial sponsored by M.D. Anderson Cancer Center. It studies Carcinoid Syndrome, Carcinoid Tumor and 2 more conditions.
Is NCT04993261 recruiting?
As of 21 Nov 2026, it is active and no longer recruiting.
Who leads NCT04993261?
The registry names Ajaykumar Morani (principal investigator, M.D. Anderson Cancer Center) as the overall official.
Where does NCT04993261 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When is NCT04993261 expected to complete?
The registry lists a primary completion date of 31 Dec 2026 and a study completion date of 31 Dec 2026. The sponsor last updated the record on 11 Aug 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.